Target intelligence / Profile preview

Signal regulatory protein beta 3, pseudogene (SIRPB3P)

Target
SIRPB3P
Molecular classification
Other (pseudogene; not a receptor, enzyme, transporter, or classical molecular target)
01

Overview

Signal regulatory protein beta 3, pseudogene (SIRPB3P) is classified by HGNC and GeneCards as a pseudogene associated with the SIRP protein family, which are transmembrane glycoproteins involved in immune cell signaling[3][5]. While functional SIRP beta proteins participate in cell communication, SIRPB3P does not encode a functional receptor and is considered a noncoding genomic locus. Like other pseudogenes, it may contribute to cellular regulation via noncoding transcripts capable of miRNA decoy or RNA interference effects, but no disease associations or drug interactions have been described for SIRPB3P specifically[1][4][6]. SIRPB3P should not be considered a canonical molecular target for drug development, but its transcript could theoretically have indirect regulatory roles, as described for some other pseudogenes. If a functional therapeutic target in the SIRP family is desired, SIRPB1 or SIRPB2 (which encode actual proteins) should be considered instead[3][5].

Other names
SIRP-beta 3 pseudogeneSIRPB3P
02

Mechanism of action

None for drugs (in general, pseudogenes may act via RNAi, microRNA decoy, or ceRNA mechanisms)

03

Biological functions

Potential regulatory RNA functions (example: pseudogenes can act as miRNA decoys, endogenous RNAi sources, or competitors for transcriptional/translational resources, thus indirectly influencing parental gene expression or cellular regulatory systems)
04

Disease associations

None known for SIRPB3P specifically; in general, pseudogenes can affect cancer biology, immune response, and disease via miRNA competition/regulatory RNA functions
05

Safety considerations

Not applicable; not a therapeutic target
06

Biomarkers

No direct biomarker usage for SIRPB3P; some pseudogenes serve as RNA-based biomarkers for disease progression in special contexts

Beyond the preview

Go deeper on Signal regulatory protein beta 3, pseudogene (SIRPB3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal regulatory protein beta 3, pseudogene (SIRPB3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call